Picture of Dormakaba Holding AG logo

DOKA Dormakaba Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
TechnologyBalancedMid CapFalling Star

Swiss stocks - Factors to watch on February 5

ZURICH/GDANSK, Feb 5 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Wednesday:
        
    ROCHE HOLDING AG  ROG.S 
    FDA approves Roche's Susvimo as the first and only
continuous delivery treatment for the leading cause of
diabetes-related blindness.
    
    COMPANY STATEMENTS
    
    DORMAKABA HOLDING AG  DOKA.S 
    Dormakaba expects net sales and adjusted EBITDA margin to be
in line with 2024/25 FY guidance.
    
    ECONOMY
    No major Swiss economic data scheduled.

 (Reporting by Zurich newsroom and Gdansk newsroom)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Dormakaba Holding AG

See all news